National Health [NHI] vs Welltower [WELL] Detailed Stock Comparison
National Health
NYSE
Loading...
Welltower
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: National Health wins in 14 metrics, Welltower wins in 6 metrics, with 0 ties. National Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | National Health | Welltower | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 23.78 | 91.01 | National Health |
| Price-to-Book Ratio | 2.21 | 3.02 | National Health |
| Debt-to-Equity Ratio | 92.14 | 47.36 | Welltower |
| PEG Ratio | -9.63 | 9.56 | National Health |
| EV/EBITDA | 17.83 | 35.30 | National Health |
| Profit Margin (TTM) | 40.77% | 12.18% | National Health |
| Operating Margin (TTM) | 62.55% | 18.66% | National Health |
| EBITDA Margin (TTM) | 62.55% | 18.66% | National Health |
| Return on Equity | 10.25% | 3.45% | National Health |
| Return on Assets (TTM) | 4.73% | 1.92% | National Health |
| Free Cash Flow (TTM) | $203.70M | $2.20B | Welltower |
| Dividend Yield | 5.08% | 1.31% | National Health |
| 1-Year Return | -1.70% | 39.85% | Welltower |
| Price-to-Sales Ratio (TTM) | 10.11 | 11.74 | National Health |
| Enterprise Value | $4.84B | $122.49B | Welltower |
| EV/Revenue Ratio | 13.79 | 13.20 | Welltower |
| Gross Profit Margin (TTM) | 96.79% | 39.80% | National Health |
| Revenue per Share (TTM) | $8 | $15 | Welltower |
| Earnings per Share (Diluted) | $3.14 | $1.79 | National Health |
| Beta (Stock Volatility) | 0.76 | 0.92 | National Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
National Health vs Welltower Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| National Health | 0.74% | 4.09% | 10.18% | 5.92% | 12.08% | 13.03% |
| Welltower | -1.53% | 3.13% | 4.13% | 12.57% | 12.36% | 33.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| National Health | -1.70% | 16.63% | 22.45% | 36.58% | 83.02% | 177.03% |
| Welltower | 39.85% | 115.88% | 180.81% | 156.52% | 265.38% | 361.42% |
Performance & Financial Health Analysis: National Health vs Welltower
| Metric | NHI | WELL |
|---|---|---|
| Market Information | ||
| Market Cap | $3.54B | $108.95B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 250,410 | 2,595,090 |
| 90 Day Avg. Volume | 243,887 | 2,434,917 |
| Last Close | $77.86 | $164.39 |
| 52 Week Range | $65.13 - $86.13 | $116.50 - $171.09 |
| % from 52W High | -9.60% | -3.92% |
| All-Time High | $91.12 (Feb 24, 2020) | $171.09 (Aug 06, 2025) |
| % from All-Time High | -14.55% | -3.92% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.12% | 0.40% |
| Quarterly Earnings Growth | -0.12% | 0.19% |
| Financial Health | ||
| Profit Margin (TTM) | 0.41% | 0.12% |
| Operating Margin (TTM) | 0.63% | 0.19% |
| Return on Equity (TTM) | 0.10% | 0.03% |
| Debt to Equity (MRQ) | 92.14 | 47.36 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $33.73 | $53.98 |
| Cash per Share (MRQ) | $0.71 | $6.59 |
| Operating Cash Flow (TTM) | $212.50M | $2.61B |
| Levered Free Cash Flow (TTM) | $179.09M | $2.07B |
| Dividends | ||
| Last 12-Month Dividend Yield | 5.08% | 1.31% |
| Last 12-Month Dividend | $3.60 | $2.01 |
Valuation & Enterprise Metrics Analysis: National Health vs Welltower
| Metric | NHI | WELL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 23.78 | 91.01 |
| Forward P/E | 23.78 | 89.51 |
| PEG Ratio | -9.63 | 9.56 |
| Price to Sales (TTM) | 10.11 | 11.74 |
| Price to Book (MRQ) | 2.21 | 3.02 |
| Market Capitalization | ||
| Market Capitalization | $3.54B | $108.95B |
| Enterprise Value | $4.84B | $122.49B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 13.79 | 13.20 |
| Enterprise to EBITDA | 17.83 | 35.30 |
| Risk & Other Metrics | ||
| Beta | 0.76 | 0.92 |
| Book Value per Share (MRQ) | $33.73 | $53.98 |
Financial Statements Comparison: National Health vs Welltower
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NHI | WELL |
|---|---|---|
| Revenue/Sales | $89.30M | $2.39B |
| Cost of Goods Sold | $2.89M | $1.46B |
| Gross Profit | $86.41M | $926.20M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $47.88M | $378.58M |
| EBITDA | $66.48M | $898.66M |
| Pre-Tax Income | $33.82M | $198.71M |
| Income Tax | N/A | $-5.52M |
| Net Income (Profit) | $33.82M | $257.27M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NHI | WELL |
|---|---|---|
| Cash & Equivalents | $135.00M | $3.50B |
| Total Current Assets | $506.42M | $7.19B |
| Total Current Liabilities | $522.52M | $1.70B |
| Long-Term Debt | $815.79M | $17.01B |
| Total Shareholders Equity | $1.44B | $34.58B |
| Retained Earnings | $2.64B | $-8.40B |
| Property, Plant & Equipment | N/A | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NHI | WELL |
|---|---|---|
| Operating Cash Flow | $55.53M | $699.61M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $46.48M | $587.44M |
| Debt Repayment | $-145.11M | $-134.28M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | NHI | WELL |
|---|---|---|
| Shares Short | 1.87M | 10.24M |
| Short Ratio | 7.72 | 4.14 |
| Short % of Float | 0.05% | 0.02% |
| Average Daily Volume (10 Day) | 250,410 | 2,595,090 |
| Average Daily Volume (90 Day) | 243,887 | 2,434,917 |
| Shares Outstanding | 45.69M | 635.29M |
| Float Shares | 43.92M | 667.92M |
| % Held by Insiders | 0.02% | 0.00% |
| % Held by Institutions | 0.75% | 0.99% |
Dividend Analysis & Yield Comparison: National Health vs Welltower
| Metric | NHI | WELL |
|---|---|---|
| Last 12-Month Dividend | $3.60 | $2.01 |
| Last 12-Month Dividend Yield | 5.08% | 1.31% |
| 3-Year Avg Annual Dividend | $3.60 | $2.09 |
| 3-Year Avg Dividend Yield | 1.50% | 0.68% |
| 3-Year Total Dividends | $10.80 | $6.28 |
| Ex-Dividend Date | Mar 31, 2025 | Feb 25, 2025 |